Table 2 Baseline characteristics of included participants

N

17

Male sex, n (%)

14 (82%)

Age, years

49 (20–64)

Visiting friends and relatives, n(%)

8 (47%)

Percentage of infected erythrocytes

1% (0.1–40%)

Patients with complicated malaria, n (%)

5 (31%)

 Hyperparasitaemia (> 10%)

4

 Shock, needing vasopressor support

1

 Spontaneous bleeding

1

 Haemoglobinuria

1

 Acute kidney injury

1

GCS at presentation (median, range)

15 (12–15)

Neurological symptoms at presentation, n(%)

 Headaches

7 (41%)

 Aphasia

2 (12%)

 Disorientation

2 (12%)

 Somnolence

1 (6%)

Haemoglobin at presentation, g/dl

13.1 (10.3–15.7)

White blood count at presentation, /µl

4.8 (3.7–10.3)

Thrombocyte count at presentation, /µl

61 (11–209)

Treatment regimens, n (%)

 Artesunate, followed by Atovaquone/proguanil

5 (29%)

 Dihydroartemisinin/piperaquine

6 (35%)

 Atovaquone/proguanil

5 (29%)

 Mefloquine

1 (6%)